The Korean Journal of Internal Medicine

Search

Close

Original Article
Korean J Med. 2008;74(2):198-202.
증례 : 게피티닙 치료로 호전된 폐선암의 전이성 수막암종증 1예
유성근 . 박원종 . 박찬서 . 진현정 . 신경철 . 정진홍 . 이관호, , , , , ,
A case of leptomeningeal metastasis from adenocarcinoma of the lung improved by treatment with Gefitinib
Sung Ken Yu, Won Jong Park, Chan Soh Park, Hyun Jung Chin, Kyeong Cheol Shin, Jin Hong Chung, Kwan Ho Lee
경희대학교 의과대학 순환기내과학교실


Abstract
Leptomeningeal metastasis occurs in approximately 1% of patients with non-small cell lung cancer and this is an extremely serious complication. Without treatment, the median survival of patients is 4~6 weeks. The treatment options currently available are limited and achieve only modest results. Gefitinib was recently approved for the teatment of advanced/refractory non-small cell lung cancer. In addition, there have been case reports showing activity of gefitinib against brain metastasis in non-small cell lung cancer patients. However, there is limited data on the ability of gefitinib to cross the blood-brain barrier. We report the case of a patient with leptomeningeal metastasis from adenocarcinoma of the lung that had a dramatic response to gefitinib treatment.

Keywords :Leptomeningeal metastasis, Non-small cell lung cancer, Gefitinib
hanmi ckdpharm. AMGEN
Memo patch yungjin daewoongbio

Go to Top